HI
Humankind Investments Portfolio holdings
AUM
$410M
This Quarter Return
+8.71%
1 Year Return
+11.36%
3 Year Return
+48.94%
5 Year Return
–
10 Year Return
–
AUM
$79.4M
AUM Growth
+$79.4M
(+21%)
Cap. Flow
+$8.76M
Cap. Flow
% of AUM
11.03%
Top 10 Holdings %
Top 10 Hldgs %
33.69%
Holding
108
New
9
Increased
84
Reduced
13
Closed
2
Top Buys
| 1 |
Verizon
VZ
|
$805K |
| 2 |
Johnson & Johnson
JNJ
|
$422K |
| 3 |
Bristol-Myers Squibb
BMY
|
$379K |
| 4 |
Thermo Fisher Scientific
TMO
|
$359K |
| 5 |
VMW
VMware, Inc
VMW
|
$346K |
Top Sells
| 1 |
Bunge Global
BG
|
$340K |
| 2 |
PPD
PPD, Inc. Common Stock
PPD
|
$328K |
| 3 |
CF Industries
CF
|
$272K |
| 4 |
Spectrum Brands
SPB
|
$228K |
| 5 |
Corteva
CTVA
|
$81.1K |
Sector Composition
| 1 | Healthcare | 38.15% |
| 2 | Consumer Staples | 17.37% |
| 3 | Communication Services | 14.41% |
| 4 | Materials | 8.95% |
| 5 | Industrials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Verizon
VZ
$186B
| $4.47M | 5.63% |
85,962
+15,495
| +22% | +$805K |
|
2
Alphabet (Google) Class A
GOOGL
$2.57T
| $4.23M | 5.32% |
1,459
+32
| +2% | +$92.7K |
|
|
3
Corteva
CTVA
$50.4B
| $3.53M | 4.45% |
74,649
-1,716
| -2% | -$81.1K |
|
|
4
Johnson & Johnson
JNJ
$427B
| $2.28M | 2.87% |
13,318
+2,470
| +23% | +$422K |
|
5
Pfizer
PFE
$141B
| $2.26M | 2.84% |
38,219
+2,216
| +6% | +$131K |
|
|
6
Bunge Global
BG
$16.8B
| $2.15M | 2.71% |
23,045
-3,642
| -14% | -$340K |
|
7
Procter & Gamble
PG
$368B
| $2.12M | 2.67% |
12,964
+1,155
| +10% | +$189K |
|
8
HCA Healthcare
HCA
$94.5B
| $1.96M | 2.47% |
7,633
+1,088
| +17% | +$280K |
|
9
American Water Works
AWK
$28B
| $1.91M | 2.41% |
10,132
+1,560
| +18% | +$295K |
|
10
GE Aerospace
GE
$292B
| $1.84M | 2.32% |
19,507
+2,036
| +12% | +$192K |
|
11
AbbVie
ABBV
$372B
| $1.75M | 2.21% |
12,949
+1,560
| +14% | +$211K |
|
|
12
Bristol-Myers Squibb
BMY
$96B
| $1.54M | 1.94% |
24,743
+6,071
| +33% | +$379K |
|
13
PepsiCo
PEP
$204B
| $1.53M | 1.93% |
8,804
+640
| +8% | +$111K |
|
14
Deere & Co
DE
$129B
| $1.5M | 1.89% |
4,382
+487
| +13% | +$167K |
|
15
Merck
MRK
$210B
| $1.25M | 1.58% |
16,330
+1,233
| +8% | +$94.5K |
|
16
Eli Lilly
LLY
$657B
| $1.22M | 1.54% |
4,431
+564
| +15% | +$156K |
|
17
McKesson
MCK
$85.4B
| $1.17M | 1.48% |
4,720
+57
| +1% | +$14.2K |
|
18
Amgen
AMGN
$155B
| $1.12M | 1.41% |
4,992
+879
| +21% | +$198K |
|
19
Xylem
XYL
$34.5B
| $1.11M | 1.4% |
9,284
+1,062
| +13% | +$127K |
|
20
Labcorp
LH
$23.1B
| $1.1M | 1.38% |
3,485
+584
| +20% | +$183K |
|
21
Ecolab
ECL
$78.6B
| $1.08M | 1.36% |
4,590
+215
| +5% | +$50.4K |
|
22
UnitedHealth
UNH
$281B
| $1.06M | 1.34% |
2,111
+164
| +8% | +$82.4K |
|
23
IQVIA
IQV
$32.4B
| $1.04M | 1.3% |
3,668
+197
| +6% | +$55.6K |
|
|
24
Thermo Fisher Scientific
TMO
$186B
| $1.01M | 1.27% |
1,513
+538
| +55% | +$359K |
|
25
FMC
FMC
$4.88B
| $936K | 1.18% |
8,519
-633
| -7% | -$69.5K |
|